Aoxing Pharmaceutical Company, Inc. (AOXG)
OTCMKTS: AOXG · Delayed Price · USD
0.0051
0.00 (0.00%)
Apr 12, 2024, 1:28 PM EDT - Market closed
AOXG Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 0 | 0 | 0 | 6.91 | 5.37 | 2.33 | 4.01 | 3.68 | Upgrade
|
| Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 6.91 | 5.37 | 2.33 | 4.01 | 3.68 | Upgrade
|
| Cash Growth | - | - | - | - | - | 28.68% | 130.57% | -41.87% | 8.83% | 32.92% | Upgrade
|
| Receivables | 0 | 0 | 0 | 0 | 0 | 11.2 | 5.85 | 3.89 | 2.84 | 2.8 | Upgrade
|
| Inventory | 0 | 0 | 0 | 0 | 0 | 2.84 | 3.24 | 2.2 | 2.62 | 1.81 | Upgrade
|
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 5.91 | 6.63 | 2.51 | 2.42 | 1.23 | Upgrade
|
| Total Current Assets | 0 | 0 | 0 | 0 | 0 | 26.87 | 21.1 | 10.92 | 11.89 | 9.52 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 25.6 | 28.65 | 26.42 | 26.94 | 26.96 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.19 | 0.29 | 0.4 | Upgrade
|
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.91 | Upgrade
|
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 1.88 | 0.48 | 0.55 | 0.61 | 1.3 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 1.88 | 2.71 | 0 | 0 | 0 | Upgrade
|
| Total Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 29.36 | 31.94 | 27.15 | 27.84 | 35.57 | Upgrade
|
| Total Assets | 0 | 0 | 0 | 0 | 0 | 56.23 | 53.04 | 38.07 | 39.73 | 45.09 | Upgrade
|
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 2.71 | 3.87 | 4.17 | 3.41 | 2.76 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0.41 | 0.29 | 0.73 | 0.52 | 0.32 | Upgrade
|
| Current Debt | 0 | 0 | 0 | 0 | 0 | 25.47 | 30.43 | 25.9 | 11.78 | 12.06 | Upgrade
|
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 9.22 | 6.65 | 3.42 | 5.99 | 3.49 | Upgrade
|
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 37.82 | 41.24 | 34.21 | 21.7 | 18.63 | Upgrade
|
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 1.37 | 7.5 | 10.12 | 3.5 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 0 | 0.34 | 0.37 | 0.37 | 3.33 | 1.69 | Upgrade
|
| Total Long-Term Liabilities | 0 | 0 | 0 | 0 | 0 | 0.34 | 1.74 | 7.87 | 13.45 | 5.19 | Upgrade
|
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 38.16 | 42.98 | 42.08 | 35.15 | 23.82 | Upgrade
|
| Total Debt | 0 | 0 | 0 | 0 | 0 | 25.47 | 31.8 | 33.4 | 21.9 | 15.56 | Upgrade
|
| Debt Growth | - | - | - | - | - | -19.90% | -4.78% | 52.53% | 40.71% | 24.83% | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Retained Earnings | 0 | 0 | 0 | 0 | 0 | -56.29 | -58.35 | -63.85 | -55.63 | -38.83 | Upgrade
|
| Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 1.72 | 3.07 | 2.98 | 2.96 | 2.66 | Upgrade
|
| Shareholders' Equity | 0 | 0 | 0 | 0 | 0 | 19.14 | 11.24 | -2.51 | 5.67 | 21.88 | Upgrade
|
| Total Liabilities and Equity | 0 | 0 | 0 | 0 | 0 | 56.23 | 53.04 | 38.07 | 39.73 | 45.09 | Upgrade
|
| Net Cash / Debt | 0 | 0 | 0 | 0 | 0 | -18.56 | -26.43 | -31.07 | -17.89 | -11.88 | Upgrade
|
| Net Cash Per Share | - | - | - | - | - | -0.25 | -0.42 | -0.62 | -0.36 | -0.24 | Upgrade
|
| Working Capital | 0 | 0 | 0 | 0 | 0 | -10.95 | -20.14 | -23.29 | -9.81 | -9.11 | Upgrade
|
| Book Value Per Share | - | - | - | - | - | 0.26 | 0.18 | -0.05 | 0.11 | 0.44 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.